A venture builder that partners with entrepreneurs to develop healthcare companies aimed at improving quality, experience, and cost-efficiency.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
Triple Aim Partners collaborates with entrepreneurs to create and scale healthcare companies that enhance quality, experience, and cost-effectiveness. They have co-founded and launched multiple companies focused on value-based care, including Prospero Health, ArchWell Health, and firsthand.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Triple Aim Partners Management Team
Triple Aim Partners Valuations & Financials
View real-time NPM data on Triple Aim Partners stock including daily Triple Aim Partners stock price estimates, valuation history, and historical share price information. Access Triple Aim Partners financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track Triple Aim Partners pricing across six independent market signals. Looking for private company due diligence data sources on Triple Aim Partners? Get in touch to learn more.
Similar Companies
like Triple Aim Partners
Color
Healthcare & Life Sciences
Physician-ordered genetic testing with comprehensive support, utilizing advanced software and a certified laboratory.
Cityblock
Healthcare & Life Sciences
Tech-driven care provider for communities with complex needs.
Elligo Health Research
Healthcare & Life Sciences
Connects healthcare sites, sponsors, and patients to streamline clinical trial access through technology and data-driven solutions.
Benchling
Healthcare & Life Sciences
Cloud based platform for research and development in biotechnology.
OpenEvidence
Healthcare & Life Sciences
Empowers clinicians who seek evidence‑based insights by delivering AI‑summarized medical research at the point of care.
Virta Health
Healthcare & Life Sciences
Online specialty medical clinic focused on reversing type 2 diabetes.
Cedar
Healthcare & Life Sciences
The tech platform uses modern intelligence to improve healthcare financial experiences for everyone.
Eikon Therapeutics
Healthcare & Life Sciences
Uses revolutionary technology to discover novel treatments for life-threatening diseases.
FAQ
We have answers
Triple Aim Partners stock does not trade on public stock exchanges. Triple Aim Partners stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Triple Aim Partners stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Triple Aim Partners Stock does not trade on public stock exchanges. In order to sell Triple Aim Partners shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Triple Aim Partners does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Triple Aim Partners share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for Triple Aim Partners stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Triple Aim Partners stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Triple Aim Partners stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Triple Aim Partners is a private company and has not had an IPO. There is currently no Triple Aim Partners IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Triple Aim Partners IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
